证券记录 · 已归档季度
DOCS
Doximity, Inc. · Healthcare · Medical - Healthcare Information Services
17被追踪持有人
+2Δ持有人
19.67M持有股份
$1.05B报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +13.3% ·
股份流向 +8.3% ·
净新建仓位 +11.8%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | -8 | 101.96M | $2.11B | +7 | −14 |
| Q1 2026 | 124 | -12 | 93.12M | $2.18B | +2 | −15 |
| Q4 2025 | 137 | +3 | 98.50M | $4.36B | +5 | −1 |
| Q3 2025 | 20 | -1 | 62.52M | $4.57B | — | −2 |
| Q2 2025 | 19 | 0 | 60.43M | $3.71B | +1 | −1 |
| Q1 2025 | 16 | -1 | 22.41M | $1.30B | +1 | −2 |
| Q4 2024 | 17 | +2 | 19.67M | $1.05B | +2 | — |
| Q3 2024 | 14 | +1 | 14.27M | $621.81M | +2 | −1 |
| Q2 2024 | 13 | — | 13.99M | $391.40M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 4.94M | -7.8% | $263.95M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 4.94M | -7.8% | $263.95M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 4.94M | -7.8% | $263.95M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 4.94M | -7.8% | $263.95M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 3.89M | — | $207.53M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 2.95M | +3.3% | $157.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 2.95M | +3.3% | $157.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 1.85M | +9.8% | $98.65M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Capital World Investors ✦ | 1.71M | 0.0% | $91.55M | 0.0% | Held | 3 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 1.51M | +708.6% | $80.64M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 972.16K | +180.4% | $51.90M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 972.16K | +180.4% | $51.90M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 896.70K | +381.7% | $47.87M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 423.01K | +1702.9% | $22.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 423.01K | +1702.9% | $22.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 423.01K | +1702.9% | $22.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 423.01K | +1702.9% | $22.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 180.74K | -41.4% | $9.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 180.74K | -41.4% | $9.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 140.70K | -1.9% | $7.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Norges Bank ✦ (被动) | 81.81K | -94.0% | $4.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Marshall Wace ✦ | 58.87K | 新增 | $3.14M | 0.0% | New | 1 | SEC ↗ |
| 23 | Marshall Wace ✦ | 58.87K | 新增 | $3.14M | 0.0% | New | 1 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 47.99K | -11.7% | $2.56M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Wellington Management ✦ | 6.66K | 新增 | $355,364 | 0.0% | New | 1 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 4.41K | -90.1% | $235,290 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Bridgewater Associates ✦ | 4.22K | -15.1% | $225,413 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $3.14M | 0.0% |
| Marshall Wace | $3.14M | 0.0% |
| Wellington Management | $355,364 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 418 持有人, 119.59M 股份, $2.71B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Sitaram Siddharth
Officer · 1.77K 股 · $44,144
Aug 07
Cabral Timothy S
Director · 7.50K 股 · $293,325
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据